as of 04-07-2026 4:00pm EST
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
| Founded: | 1972 | Country: | United States |
| Employees: | N/A | City: | LEHI |
| Market Cap: | 424.6M | IPO Year: | 1995 |
| Target Price: | $28.33 | AVG Volume (30 days): | 124.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | quarterly |
| EPS: | 1.06 | EPS Growth: | 165.00 |
| 52 Week Low/High: | $11.24 - $28.14 | Next Earning Date: | 05-05-2026 |
| Revenue: | $480,144,000 | Revenue Growth: | 5.67% |
| Revenue Growth (this year): | 7.76% | Revenue Growth (next year): | 3.82% |
| P/E Ratio: | 23.21 | Index: | N/A |
| Free Cash Flow: | 28.8M | FCF Growth: | +101.31% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
EVP & President, Asia
Avg Cost/Share
$24.52
Shares
15,383
Total Value
$377,191.16
Owned After
55,693
SEC Form 4
EVP & President, Europe
Avg Cost/Share
$24.35
Shares
19,516
Total Value
$475,214.60
Owned After
85,154
SEC Form 4
SVP, Chief Accounting Officer
Avg Cost/Share
$24.70
Shares
4,000
Total Value
$98,800.00
Owned After
46,405
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Norman Daniel C | NATR | EVP & President, Asia | Mar 13, 2026 | Sell | $24.52 | 15,383 | $377,191.16 | 55,693 | |
| Yates Bryant J | NATR | EVP & President, Europe | Mar 13, 2026 | Sell | $24.35 | 19,516 | $475,214.60 | 85,154 | |
| Lanoy Jonathan David | NATR | SVP, Chief Accounting Officer | Mar 13, 2026 | Sell | $24.70 | 4,000 | $98,800.00 | 46,405 |
SEC 8-K filings with transcript text
Mar 10, 2026 · 100% conf.
1D
+8.43%
$27.28
Act: -5.53%
5D
+12.92%
$28.41
20D
+16.84%
$29.40
natr-202603100000275053false00002750532025-11-062025-11-06
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 10, 2026
(Exact name of registrant specified in its charter)
Utah 001-34483 87-0327982 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2901 West Bluegrass Blvd., Suite 100 Lehi, Utah 84043 (Address of principal executive offices and zip code)
Registrant’s telephone, including area code: (801) 341-7900
N/A (Former name and former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each ClassTrading SymbolName of each exchange on which registered Common Stock, no par valueNATRNasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On March 10, 2026, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing financial results for the fourth quarter and full year ended December 31, 2025. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assists management and investors in evaluating and comparing period-to-period results in a more meaningful and consistent manner. A reconciliation of GAAP to non-GAAP results is provided in the press release.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Compensatory Arrangements of Certain Officers
On February 24, 2026, the Compensation Committee of the Company approved an increase to the base salary of the Company’s Chief Financial Officer, Mr. L. Shane Jones, from $478,400 to $492,752 which increase is effective March 8, 2026.
On February 24, 2026, the Compensation Committee of the Company approved an increase to the base salary of the Company’s Executive Vice President, Asia, Mr. Dan Norman, from $446,250 to $459,638, which increase is effective March 8, 2026.
Item 9.01 Financial Statements and Exhibits
Item No. Exhibit 99.1 Press release issued by the Company, dated March 10, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 10, 2026By:/s/ Nathan G. Brower Nathan G. Brower, Executive Vice President, General Counsel and Corporate Secretary
Nov 6, 2025 · 100% conf.
1D
+4.80%
$14.42
Act: +30.23%
5D
+6.62%
$14.67
Act: +50.73%
20D
+9.81%
$15.11
Act: +59.01%
natr-202511060000275053false00002750532025-11-062025-11-06
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2025
(Exact name of registrant specified in its charter)
Utah 001-34483 87-0327982 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2901 West Bluegrass Blvd., Suite 100 Lehi, Utah 84043 (Address of principal executive offices and zip code)
Registrant’s telephone, including area code: (801) 341-7900
N/A (Former name and former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each ClassTrading SymbolName of each exchange on which registered Common Stock, no par valueNATRNasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 6, 2025, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended September 30, 2025. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assists management and investors in evaluating and comparing period-to-period results in a more meaningful and consistent manner. A reconciliation of GAAP to non-GAAP results is provided in the press release.
Item 9.01 Financial Statements and Exhibits
Item No. Exhibit 99.1 Press release issued by the Company, dated November 6, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 6, 2025By:/s/ Nathan G. Brower Nathan G. Brower, Executive Vice President, General Counsel and Corporate Secretary
Jul 31, 2025
natr-202507310000275053false00002750532025-07-312025-07-31
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 31, 2025
(Exact name of registrant specified in its charter)
Utah 001-34483 87-0327982 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2901 West Bluegrass Blvd., Suite 100 Lehi, Utah 84043 (Address of principal executive offices and zip code)
Registrant’s telephone, including area code: (801) 341-7900
N/A (Former name and former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each ClassTrading SymbolName of each exchange on which registered Common Stock, no par valueNATRNasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 31, 2025, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended June 30, 2025. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assists management and investors in evaluating and comparing period-to-period results in a more meaningful and consistent manner. A reconciliation of GAAP to non-GAAP results is provided in the press release.
Item 9.01 Financial Statements and Exhibits
Item No. Exhibit 99.1 Press release issued by the Company, dated July 31, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 31, 2025By:/s/ Nathan G. Brower Nathan G. Brower, Executive Vice President, General Counsel and Corporate Secretary
See how NATR stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "NATR Nature's Sunshine Products Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.